Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
recent articles
Much like whole slides themselves, blogs I am finding have some of the same characteristics for different reasons - they are persistent, consistent and efficient. One can choose to get daily feeds or follow on a reader seamlessly. ...
For those of us who trained and/or spent time at the Armed Forces Institute of Pathology (AFIP) during our careers have wonderful memories of the experience and the wealth of material and expertise at "windowless buidling" on the...
In the September 1 edition of Genetic Engineering & Biotechnology News there is a story by Steve Potts, Ph.D., who is the worldwide director of biopharma at Aperio Technologies . The article starts with: The vast majority of drug compounds...
Through the Critical Section I came across a link to an article by a tech blogger by the name of Dana Blakenhorn who has been a business journalist since 1978 and has covered technology since 1982. Here is a short take entitled "Dr....
The New York Times (9/19, C2, Helft) reports that on Thursday, Sergey Brin, a Google co-founder, announced, via his blog, "that he has a gene mutation that increases his likelihood of contracting Parkinson's disease, a degenerative...
This is my nearly 500th post since June 22 of last year. As always, I welcome your comments, criticisms, suggestions and e-mails. With the growing popularity of the blog, I recently registered www.digitalpathologyblog.com as another URL...
